Staphylococcal enterotoxin B mutants (N23K and F44S): Biological effects and vaccine potential in a mouse model

Vaccine

Volumn 15, Issue 2, 1997, Pages 133-139

  Woody, Mary Alice ^a   Krakauer, Teresa ^a   Stiles, Bradley G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Mutant proteins; Staphylococcal enterotoxin B; Superantigen vaccines

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; MUTANT PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; CYTOKINES; ENTEROTOXINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MUTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0031081616     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00166-1     Document Type: Article

References (35)

1. 1 Bohach, G.A., Fast, D.F., Nelson, R.D. and Schlievert, P.M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 1990, 17, 251-272
2. 2 Crass, B.A. and Bergdoll, M.S. Toxin involvement in toxic shock syndrome. J. Infect. Dis. 1986, 153, 918-926
3. 3 Prasad, G.S., Earhart, C.A., Murray, D.L., Novick, R.P., Schlievert, P.M. and Ohlendorf, D.H. Structure of toxic shock syndrome toxin 1. Biochemistry 1993, 32, 13761-13766
4. 4 Swaminathan, S., Furey, W., Pletcher, J. and Sax, M. Crystal structure of Staphylococcal enterotoxin B, a superantigen. Nature 1992, 359, 801-806
5. 5 Marrack, P. and Kappler, J. The Staphylococcal enterotoxins and their relatives. Science 1990, 248, 705-711
6. 6 Matthys, B., Mitera, T., Heremans, H., Van Damme, J. and Billiau, A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect. Immun. 1995, 63, 1158-1164
7. 7 Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P.H. and Wagner, H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 1992, 175, 91-98
8. 8 Stiles, B.G., Bavari, S., Krakauer, T. and Ulrich, R.G. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect. Immun. 1993, 61, 5333-5338
9. 9 Stiles, B.G., Krakauer, T. and Bonventre, P.F. Biological activity of toxic shock syndrome toxin 1 and site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect. Immun. 1995, 63, 1229-1234
10. 10 Pettit, G.W., Elwell, M.R. and Jahrling, P.B. Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J. Infect. Dis. 1977, 135, 646-648
11. 11 Stone, R.L. and Schlievert, P.M. Evidence for the involvement of endotoxin in toxic shock syndrome. J. Infect. Dis. 1987, 155, 682-689
12. 12 Bonventre, P.F., Heeg, H., Cullen, C. and Lian, C-J. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 1993, 61, 793-799
13. 13 Harris, T.O., Hufnagle, W.O. and Betley, M.J. Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation. Infect. Immun. 1993, 61, 2059-2068
14. 14 Hoffmann, M.L., Jablonski, L.M., Crum, K.K. et al. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect. Immun. 1994, 62, 3396-3407
15. 15 Kappler, J.W., Herman, A., Clements, J. and Marrack, P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 1992, 175, 387-396
16. 16 Murray, D.L., Prasad, G.S., Earhart, C.A. et al. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. J. Immun. 1994, 152, 87-95
17. 17 Jardetzky, T.S., Brown, J.H., Gorga, J.C. et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994, 368, 711-718
18. 18 Kim, J., Urban, R.G., Strominger, J.L. and Wiley, D.C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994, 266, 1870-1878
19. 19 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970, 227, 680-685
20. 20 LeClaire, R.D., Kell, W., Bavari, S., Smith, T. and Hunt, R.E. Protective effects of niacinamide in staphylococcal enterotoxin B induced toxicity. Toxicology 1996, 107, 69-81
21. 21 Metzroth, B., Marx, T., Linnig, M. and Fleischer, B. Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins. Infect. Immun. 1993, 61, 2445-2452
22. 22 Van Regenmortel, M.H.V. Molecular dissection of protein antigens. In: Structure of Antigens, Vol. I (Ed. Van Regenmortel, M.H.V.). CRC Press, Inc., Boca Raton, Florida, 1992, pp. 1-27
23. 23 Bohach, G.A., Hovde, C.J., Handley, J.P. and Schlievert, P.M. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect. Immun. 1988, 56, 400-404
24. 24 Bonventre, P.F., Thompson, M.R., Adinolfi, L.E., Gillis, Z.A. and Parsonnet, J. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect. Immun. 1988, 56, 135-141
25. 25 Takei, S., Arora, Y.K. and Walker, S.M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 1993, 91, 602-607
26. 26 Bonventre, P.F., Linnemann, C., Weckbach, L.S. et al. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J. Infect. Dis. 1984, 150, 662-666
27. 27 Bonventre, P.F., Heeg, H., Edwards, C.K. and Cullen, C.M. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect. Immun. 1995, 63, 509-515
28. 28 Drynda, A., Konig, B., Bonventre, P.F. and Konig, W. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect. Immun. 1995, 63, 1095-1101
29. 29 Cullen, C.M., Blanco, L.R., Bonventre, P.F. and Choi, E. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T cell activation. Infect. Immun. 1995, 63, 2141-2146
30. 30 Garbe, P.L., Arko, J.R., Reingold, A.L. et al. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome: evidence for additional toxins. J. Am. Med. Assoc. 1985, 253, 2538-2542
31. 31 Carlsson, R. and Sjogren, H.O. Kinetics of IL-2 and interferon-γ production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell. Immun. 1985, 96, 175-183
32. 32 Jupin, C., Anderson, S., Damais, C., Alouf, J.E. and Parant, M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J. Exp. Med. 1988, 167, 752-761
33. 33 Krakauer, T. Differential inhibitory effects of interleukin-10, interleukin-4, and dexamethasone on staphylococcal enterotoxin-induced cytokine production and T cell activation. J. Leuk. Biol. 1995, 57, 450-454
34. 34 Harris, T.O., Grossman, D., Kappler, J.W., Marrack, P., Rich, R.R. and Betley, M.J. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect. Immun. 1993, 61, 3175-3183
35. 35 Harris, T.O. and Betley, M.J. Biological activities of staphylococcal enterotoxin A mutants with N-terminal substitutions. Infect. Immun. 1995, 63, 2133-2140